Expedia Shares Fall 1.65 as Trading Volume Surges 54% to Rank 349th Amid Mixed Analyst Sentiment and Institutional Buying

Expedia Group (EXPE) closed on July 30 with a 1.65% decline, trading at a volume of $0.36 billion—a 54.34% increase from the prior day, ranking it 349th in trading activity. The stock has faced mixed analyst sentiment, with recent institutional buying activity and updated price targets highlighting market dynamics. Meeder Asset Management Inc. significantly increased its holdings by 1,505.4% in Q1, now owning $248,000 worth of shares, while other funds like Hunter Associates and Praxis Investment Management also boosted stakes. Analysts have varied outlooks, including UBS maintaining a "Neutral" rating with a raised price target of $182 and Bank of America upgrading its target to $211 with a "Buy" rating. The stock’s 52-week performance outpaced the S&P 500 but underperformed year-to-date, reflecting ongoing challenges in U.S. travel demand post-Q1 earnings miss.

Expedia’s Q1 results, released May 8, revealed weaker-than-expected revenue growth and earnings, leading to a 7.3% drop in shares. Despite a 3.4% year-over-year revenue increase, the company fell short of estimates due to subdued domestic travel demand. Adjusted EPS rose 90.5% to $0.41 but missed expectations by 4.8%. Analysts project 28.8% EPS growth for the current fiscal year, though mixed earnings surprises over the past four quarters underscore operational uncertainties. Institutional ownership now accounts for 90.76% of shares, with recent purchases from global funds like Sumitomo Mitsui DS Asset Management and the State of Alaska Department of Revenue. These moves suggest confidence in Expedia’s long-term positioning despite near-term volatility.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day yielded a 166.71% return from 2022 to the present, significantly outperforming the benchmark return of 29.18%. The strategy’s excess return of 137.53% and a CAGR of 31.89% highlight its effectiveness, supported by a Sharpe ratio of 1.14 and a maximum drawdown of 0.00%. This demonstrates strong risk-adjusted performance and consistent growth, positioning the approach as a compelling option for investors seeking market-aligned returns with minimized volatility.